/
What is the difference between a mutation search and a direct gene test?
What is the difference between a mutation search and a direct gene test?
A mutation search involves reading large parts of the gene, whereas a predictive or direct gene test is an analysis for a known mutation in a family. The CanRisk Tool distinguishes between these two types of genetic test on the basis of their sensitivity. For example, the risk models used by the CanRisk Tool assume that, by default, mutation searches only detect 89% of BRCA1 mutations†, whereas direct gene tests are assumed to be 100% sensitive. As a result, the tool allows for the possibility that a mutation has been missed by a mutation search.
You can specify different mutation search sensitivities prior to running a risk calculation in the 'Advanced Options' menu in the 'Family History' section.
† Lee, A. J. et al. Enhancing the BOADICEA cancer risk prediction model to incorporate new data on RAD51C, RAD51D, BARD1, updates to tumour pathology and cancer incidences. J Med Genetics (2022)
, multiple selections available,
Related content
How were the default gene-specific genetic test sensitivities in the CanRisk Tool chosen?
How were the default gene-specific genetic test sensitivities in the CanRisk Tool chosen?
More like this
How can I change the genetic test sensitivity?
How can I change the genetic test sensitivity?
More like this
Why does the CanRisk Tool predict a high residual mutation carrier probability when the target has had a negative mutation search?
Why does the CanRisk Tool predict a high residual mutation carrier probability when the target has had a negative mutation search?
More like this
Mutation carrier probabilities in families with members that have two or more mutations or families with mutations in more than one gene
Mutation carrier probabilities in families with members that have two or more mutations or families with mutations in more than one gene
More like this
How are BRCA1 and BRCA2 mutations defined?
How are BRCA1 and BRCA2 mutations defined?
More like this
How are rare genetic pathogenic variants in BRCA1, BRCA2, PALB2, ATM, CHEK2 , RAD51C, RAD51D, and BRIP1 used in the CanRisk Tool?
How are rare genetic pathogenic variants in BRCA1, BRCA2, PALB2, ATM, CHEK2 , RAD51C, RAD51D, and BRIP1 used in the CanRisk Tool?
More like this